Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.
about
Postgenomics: Proteomics and Bioinformatics in Cancer ResearchExpression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors.Recent developments in multiplexing techniques for immunohistochemistry.Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcomeTissue Microarray Analysis Applied to Bone DiagenesisDNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma.Phenotypic composition of salivary gland tumors: an application of principal [corrected] component analysis to tissue microarray data.Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridization.Understanding cancer through proteomics.Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinomaRET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlationAssessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray.Evaluation of P16 expression in canine appendicular osteosarcoma.Creation, validation, and quantitative analysis of protein expression in vascular tissue microarrays.Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study.Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic significance for head and neck squamous cell carcinoma.Expression of p21WAF1 in Astler-Coller stage B2 colorectal cancer is associated with survival benefit from 5FU-based adjuvant chemotherapy.High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer.Distinct expression profiles of p63 variants during urothelial development and bladder cancer progressionPTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancerAdrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trialsExpression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testingTumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcomeConventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markersTopoisomerase II-alpha expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinoma.Construction and validation of a bone marrow tissue microarray.Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarraysLoss of p63 expression is associated with tumor progression in bladder cancerChromogenic in situ hybridization for alpha6beta4 integrin in breast cancer: correlation with protein expression.Gene discovery in bladder cancer progression using cDNA microarraysComparison of hepatocellular carcinoma in American and Asian patients by tissue array analysisValidation of tissue microarray technology in endometrioid cancer of the endometrium.Tissue microarrays: applications in genomic research.New developments in the staging of melanoma.
P2860
Q24800450-CA53FD33-0D13-4D0D-AF46-2880C643651FQ24803501-138DF78D-5B18-492D-B3DD-979CF38E9FC4Q26796393-D0A9AD29-0B4E-4A98-88D1-3D2E77458489Q28201662-0FCEEDF3-058D-4BDB-8086-845BB2F253C4Q28584479-9D375D35-67CD-43E6-804C-DA347207FC66Q30359384-F9631D72-5FEA-4C23-A409-8BF54E013FA9Q30828754-6EC3B246-E7C2-4BDF-B34A-FE22A234F363Q30923772-6CE98BCF-4CA7-4F0B-BE78-1807CCEB01CFQ30975373-A7956E52-6B41-42B8-9B94-D8949F62B557Q31134537-84B8322D-B7E8-462D-8AA3-AB01D0C81968Q33592904-17E04121-94D6-40D7-8F08-6404324DFBD9Q33599429-86B9CF0C-1C8C-4DAB-B557-09B465891788Q33781177-C9038A64-7CBF-45B9-A2D0-61CCB4E6F8F4Q33787998-24FC9FD8-B2BC-4678-8EFF-04ECFB788731Q33816174-1D52A989-EE09-474B-8205-11F0C0D1C23DQ33838256-3D96ABA1-A1E5-4F8B-8CE1-DBBE4F4D7913Q34411696-3CB0CBC8-158E-41A4-AE3C-F621C27E9C4AQ34492308-0059A942-0F57-48AC-8D82-A29DBFB4D2B0Q34539747-82A45C0C-677A-49E5-88DC-140D99ECA734Q34705611-4B50E62A-EC6E-4689-BCDD-7302D1EFC905Q34727321-D068FFCF-F2E4-4064-8E4B-9FF39D363C59Q34755858-E9150B7B-457A-40A1-85E1-A546746F5431Q34778769-48E41ECA-6027-4AE8-B77E-10F1564035BFQ35200395-2F9287F5-6B58-42EE-A679-6F3BB2926B23Q35558130-79AFFF6D-7C7F-4718-B6D0-9AB6C8A2B301Q35587630-B37AE46D-056A-422F-AEAB-978ABE4296FCQ35588100-0830D422-2F24-45E0-B09D-817899ACD4BAQ35748945-9B97EB0D-2DAB-40D5-B30A-C49D4A76468EQ35748966-1FDFD780-90F1-47CC-B814-6940F02DF22CQ35754783-66F7B4E4-0BB7-41D3-A154-7CFFD08E4E37Q35770181-0230D44C-A24D-4E44-869C-45136A6BEC72Q35770583-82A23B04-E633-4C05-99B3-953F78A2533CQ35788634-F8E489A7-64C5-4C5C-B727-4A6ECAD35845Q35789205-9B07662A-15A7-4DCE-BEBA-D9310AE5B0F2Q35789687-A0DA12D6-207B-40BA-9E55-D9EE0C33E489Q35791851-0EE74B68-9AC3-4427-91CB-D7DB13B78752Q35942016-9347BFC0-770B-4018-B9CA-C33F4D41B59FQ36014413-47BDED5D-5F06-4FC1-B894-50392D4FEF22Q36099365-33345181-2223-4279-BAD7-A8F86C181F98Q36276368-3B54D43D-5D00-4297-9C88-2543932A9D9F
P2860
Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Validation of tissue microarra ...... of human fibroblastic tumors.
@ast
Validation of tissue microarra ...... of human fibroblastic tumors.
@en
type
label
Validation of tissue microarra ...... of human fibroblastic tumors.
@ast
Validation of tissue microarra ...... of human fibroblastic tumors.
@en
prefLabel
Validation of tissue microarra ...... of human fibroblastic tumors.
@ast
Validation of tissue microarra ...... of human fibroblastic tumors.
@en
P2093
P2860
P1476
Validation of tissue microarra ...... of human fibroblastic tumors.
@en
P2093
A Stojadinovic
C Cordon-Cardo
M F Brennan
S Mastorides
P2860
P304
P356
10.1016/S0002-9440(10)64075-8
P407
P577
2001-04-01T00:00:00Z